Bevacirel 100 mg Injection
  1. Home
  2. Pharma Products
  3. Reliance Life Sciences Pvt Ltd
  4. Bevacirel 100 mg Injection

Bevacirel 100 mg Injection

Bevacirel 100 mg Injection contains bevacizumab 100 mg, a recombinant humanized monoclonal antibody used as an anticancer medicine. It works by blocking vascular endothelial growth factor (VEGF), which helps restrict blood-vessel growth that supports tumors. The product is supplied as a 100 mg/4 mL single-use vial for intravenous infusion.

BUY NOW

Category

Bevacizumab binds to VEGF and inhibits its biological activity, reducing the formation of new blood vessels that can supply tumor tissue. Bevacirel is used in specific cancer treatment regimens, including colorectal cancer, non-small-cell lung cancer, renal cell carcinoma, and selected ovarian and cervical cancers. The 100 mg presentation contains 100 mg of bevacizumab in 4 mL, equivalent to 25 mg/mL. It is administered by a qualified healthcare professional and requires refrigerated storage at 2°C–8°C without freezing.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 100 mg
Concentration 25 mg/mL
Pack Size 4 mL single-use vial
Dosage Form Solution for infusion
Storage 2°C–8°C

Product Also Known As

Bevacirel 100 mg Injection, Bevacirel 100 mg/4 mL Injection, Bevacirel 100 Injection, Bevacirel Bevacizumab Injection, Bevacizumab 100 mg Injection, Bevacizumab 100 mg/4 mL